Clinical analysis of rapamycin drug-eluting stent thrombosis after Primary percutaneous coronary intervention
AI Hui
ZHU Xiao-ling
YAN Hong-bing
GAO Hai
LI Nan
WANG Jiang
ZHANG Xiao-jiang
LI Shi-ying
Abstract：Objective To observe Rapamycin drug-eluting stent thrombosis after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI). Methods Primary PCI with implantation of rapamycin drug-eluting stent was performed in 521 patients with STEMI. Among them, 12 cases suffering from stent thrombosis after PCI were observed. Results The incidence of stent thrombosis was 2.5% ( 13/521), the death rate of the 12 cases in 6 months was 41.7% (5/12). Meanwhile enlarged left ventricular end diastolic diameter and reduced left ventricular ejection fraction occurred in 7 survival patients within 6 months.Conclusion Rapamycin drug-eluting stent thrombosis was a clinical incident with multiple risk factors and related to high mortality and poor prognosis.
Keywords：ST-segment elevation mycocavdial infarctionPercutaneous coronary interventionDrugeluting stentStent thrombosis
Publication Date：2008-01-01
Online Publishing Date：2026-09-14(First online date of this platform, not the publication date of the document)
Pages：3( 332-334 )